Comparative Pharmacology
Head-to-head clinical analysis: HISTAFED versus TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HISTAFED versus TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W CODEINE.
HISTAFED vs TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
HISTAFED is a combination of pseudoephedrine, a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the nasal mucosa causing vasoconstriction, and triprolidine, a first-generation antihistamine that competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract, thereby preventing histamine-mediated effects.
Codeine is a prodrug converted to morphine, a mu-opioid receptor agonist, producing analgesia and antitussive effects. Triprolidine is a first-generation antihistamine blocking H1 receptors, reducing histamine effects. Pseudoephedrine is a sympathomimetic amine acting as a decongestant via alpha-adrenergic receptor agonism in respiratory tract mucosa.
60 mg orally every 4 to 6 hours as needed; maximum 360 mg per day.
Oral: 1 tablet (triprolidine 2.5 mg, pseudoephedrine 60 mg, codeine 30 mg) every 4-6 hours as needed; maximum 4 tablets per day.
None Documented
None Documented
3-4 hours for pseudoephedrine component; shorter in children (2-3 h), prolonged in renal impairment
Codeine: 2.5-3.5 hours; clinical context: short half-life necessitates frequent dosing. Triprolidine: 3-5 hours; clinical context: typical dosing every 4-6 hours. Pseudoephedrine: 5-8 hours (alkaline urine prolongs to ~10-13 hours); clinical context: extended-release formulations available.
Renal (approximately 65% as unchanged drug and metabolites), biliary/fecal (35%)
Codeine: renal elimination of metabolites (primarily codeine-6-glucuronide, norcodeine, and morphine glucuronides); approximately 90% excreted renally, with about 10% as unchanged codeine. Triprolidine: renal elimination (80-90% as metabolites, <5% unchanged). Pseudoephedrine: renal elimination (70-90% unchanged, dependent on urine pH).
Category C
Category A/B
Antihistamine/Decongestant Combination
Antihistamine